Here we go again: COVID-19 hospital admissions have inched upward in the United States since early July in a small-scale echo of the three previous summers.
With an updated vaccine still months away, this summer bump in new hospitalizations might be concerning, but the number of patients is far lower than before. A look at what we know:
HOW BAD IS THE SPIKE?
For the week ending July 29, COVID-19 hospital admissions were at 9,056. That's an increase of about 12% from the previous week.
But it's a far cry from past peaks, like the 44,000 weekly hospital admissions in early January, the nearly 45,000 in late July 2022, or the 150,000 admissions during the omicron surge of January 2022.
“It is ticking up a little bit, but it’s not something that we need to raise any alarm bells over,” said Dr. David Dowdy, an infectious disease epidemiologist at Johns Hopkins Bloomberg School of Public Health.
It’s likely that infections are rising too, but the data is scant. Federal authorities ended the public health emergency in May, so the Centers for Disease Control and Prevention and many states no longer track the number of positive test results.
WHAT ABOUT DEATHS?
Since early June, about 500 to 600 people have died each week. The number of deaths appears to be stable this summer, although past increases in deaths have lagged behind hospitalizations.
HOW ARE WE TRACKING THE VIRUS?
The amount of the COVID-19 virus in sewage water has been rising since late June across the nation. In the coming weeks, health officials say they'll keep a close eye on wastewater levels as people return from summer travel and students go back to school.
Higher levels of COVID-19 in wastewater concentrations are being found in the Northeast and South, said Cristin Young, an epidemiologist at Biobot Analytics, the CDC's wastewater surveillance contractor.
“It’s important to remember right now the concentrations are still fairly low,” Young said, adding it's about 2.5 times lower than last summer.
“There are a couple that we’re watching, but we’re not seeing anything like delta or omicron,” Young said, referencing variants that fueled previous surges.
And mutations in the virus don't necessarily make it more dangerous.
“Just because we have a new subvariant doesn’t mean that we are destined to have an increase in bad outcomes," Dowdy said.
WHEN IS THE NEW VACCINE COMING?
This fall, officials expect to see updated COVID-19 vaccines that contain one version of the omicron strain, called XBB.1.5. It’s an important change from today’s combination shots, which mix the original coronavirus strain with last year’s most common omicron variants.
It's not clear exactly when people can start rolling up their sleeves for what officials hope is an annual fall COVID-19 shot. Pfizer, Moderna and smaller manufacturer Novavax all are brewing doses of the XBB update but the Food and Drug Administration will have to sign off on each, and the CDC must then issue recommendations for their use.
Dr. Mandy Cohen, the new CDC director, said she expects people will get their COVID-19 shots where they get their flu shots — at pharmacies and at work — rather than at dedicated locations that were set up early in the pandemic as part of the emergency response.
“This is going to be our first fall and winter season coming out of the public health emergency, and I think we are all recognizing that we are living with COVID, flu, and RSV," Cohen told The Associated Press last week. “But the good news is we have more tools than ever before.”
AP Medical Writers Lauran Neergaard and Mike Stobbe contributed to this report.
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.
Sarav Arunachalam, air pollution scientist at the University of North Carolina at Chapel Hill, joins Cheddar Climate, where he discusses what he needs to happen when it comes to EV production on a global level to help reduce the effects of climate change.
The United Nations Secretary-General said this year that his agency's warning about climate change was a 'code red for humanity.' So how will political pledges to lower emissions, increase green energy, and ramp up electric vehicle infrastructure play out, and can we reverse some climate damage next year? Vijay Vaitheeswaran, Global energy & climate innovation editor for The Economist, and host of 'To a Lesser Degree,' The Economist’s podcast on climate change, joins Cheddar Climate to discuss what we can look ahead to in 2022, including global policy shifts and investments from the private and public sectors, holding global leaders accountable, and more.
In recent years, extreme weather events like flooding and wildfires have become more frequent, and more severe - and scientists say global warming is to blame. Climate crises could leave people in need of help, and that's where Global Rescue steps in. The crisis response firm employs former Navy Seals and Army Rangers to rescue travelers from climate-related emergencies. Global Rescue CEO Dan Richards joins Cheddar Climate to discuss.
Jennifer Lotito, president and COO at the non-profit (RED), joined Cheddar to discuss the CODE (RED) campaign as the organization looks to expand its mission to support both AIDS and COVID-19 relief. She explained that people can get involved in the campaign for Giving Tuesday and ahead of World AIDS Day by shopping (RED) branded products and even using credit card rewards points to add their own support. Lotito also pointed out that COVID-19 has also impacted HIV testing as people avoid clinics out of fear of the other pandemic.
NASA indefinitely delayed a spacewalk to repair an ISS antenna, citing concerns about space debris. It was unclear if the warning from the space agency to astronauts aboard the ISS was related to the recent destruction of a non-functioning Russian satellite.
Dr. Farhan Bhatti, a family physician and Michigan State lead for the Committee to Protect Health Care, joined Cheddar to discuss the newly discovered and highly transmissible omicron variant of COVID-19. Bhatti said it is too early to draw any conclusions about the new variant but there is concern that it could eventually mutate and develop a resistance to vaccines. "Time will tell, but for now, it looks like, still, the best thing that we can do to try to limit the spread of this disease is make sure everybody gets a vaccine and make sure everybody avoids large gatherings indoors and wears masks during the wintertime especially," he said.
Jill and Carlo cover the latest developments with the Omicron variant that are spooking markets once again. Twitter's @Jack is leaving, SCOTUS takes up abortion rights and the world has a brand new republic.
A CDC panel unanimously endorsed Moderna and Pfizer Covid-19 vaccine boosters for all U.S. adults. This comes after the FDA gave its own authorization for everyone 18 and older, scrapping previous eligibility factors like age and underlying conditions. Dr. Shereef Elnahal, President and CEO of University Hospital and former New Jersey Health Commissioner, joined Cheddar News to break down the development.
The Biden Administration is set to buy 10 million courses of Pfizer's Covid pill if it gains emergency use authorization from the FDA. With this purchase, the U.S. will receive more than 13 million courses of antiviral pills aimed at treating Covid and reducing severe illness and death. Pfizer's pill has been shown to reduce risk of hospitalization and death by 89 percent, proving it could be a key tool in the fight against the pandemic. Dr. Soumi Eachempati, Co-Founder, CEO & CMO of Cleared4, joined Cheddar News to discuss.
Dr. David Dodson, Infectious Disease Specialist at Carden & Dodson MD, joined Wake Up With Cheddar to break down what we know so far about the Omicron Covid-19 variant, and why you shouldn't wait for an Omicron-specific shot to get vaccinated.
